- Home
- ANGO vs FINS Comparison
ANGO vs FINS Comparison
Compare ANGO & FINS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANGO
- FINS
- Stock Information
- Founded
- ANGO 1988
- FINS 2019
- Country
- ANGO United States
- FINS United States
- Employees
- ANGO N/A
- FINS N/A
- Industry
- ANGO Medical/Dental Instruments
- FINS Finance/Investors Services
- Sector
- ANGO Health Care
- FINS Finance
- Exchange
- ANGO Nasdaq
- FINS Nasdaq
- Market Cap
- ANGO 400.8M
- FINS 443.4M
- IPO Year
- ANGO 2004
- FINS N/A
- Fundamental
- Price
- ANGO $10.73
- FINS $13.43
- Analyst Decision
- ANGO Strong Buy
- FINS
- Analyst Count
- ANGO 3
- FINS 0
- Target Price
- ANGO $19.00
- FINS N/A
- AVG Volume (30 Days)
- ANGO 360.4K
- FINS 78.0K
- Earning Date
- ANGO 10-02-2025
- FINS 01-01-0001
- Dividend Yield
- ANGO N/A
- FINS 9.97%
- EPS Growth
- ANGO N/A
- FINS N/A
- EPS
- ANGO N/A
- FINS N/A
- Revenue
- ANGO $292,498,000.00
- FINS N/A
- Revenue This Year
- ANGO $7.13
- FINS N/A
- Revenue Next Year
- ANGO $6.28
- FINS N/A
- P/E Ratio
- ANGO N/A
- FINS N/A
- Revenue Growth
- ANGO N/A
- FINS N/A
- 52 Week Low
- ANGO $5.83
- FINS $11.61
- 52 Week High
- ANGO $13.50
- FINS $12.57
- Technical
- Relative Strength Index (RSI)
- ANGO 67.75
- FINS 66.11
- Support Level
- ANGO $10.66
- FINS $13.20
- Resistance Level
- ANGO $11.04
- FINS $13.37
- Average True Range (ATR)
- ANGO 0.31
- FINS 0.11
- MACD
- ANGO 0.07
- FINS 0.01
- Stochastic Oscillator
- ANGO 75.59
- FINS 80.00
About ANGO AngioDynamics Inc.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.
About FINS Angel Oak Financial Strategies Income Term Trust of Beneficial Interest
Angel Oak Financial Strats Income Term is a non-diversified, closed-end management investment company. The fund's objective is to seek current income with a secondary objective of total return. In pursuing its investment objective, the fund invests mainly in debt issued by financial institutions, including subordinated debt, unrated debt, senior debt, and high-yield securities.